Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FATT I trial of adipose-derived autologous stem cells for complex perianal fistulas
2006-003370-95Phase 3Terminated
- Sponsor
- Cellerix S.A.
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of CX401 and tisseel in anal fistula (3 arms), sponsored by Cellerix S.A. Started Jul 2007; status: terminated.
02
Drugs
CX401tisseel
03
Conditions
anal fistula
Beyond the preview
Go deeper on 2006-003370-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003370-95.